Sanofi S.A. is a French multinational pharmaceutical company headquartered in Gentilly, France, as of 2013 the world's fifth-largest by prescription sales. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis ..... The architecture of the head office is of the predominant style of the area surrounding the ...
Jun 26, 2013 ... In a judgment dated 10 May 2013 (Sanofi-Aventis Deutschland GmbH v. Genentech, Inc., Appeal No 2012-1454) the United States Court of ...
SANOFI-AVENTIS DEUTSCHLAND v. ... sively licensed to Sanofi-Aventis Deutschland GmbH (a company ..... The district court found that litigation became “rea-.
Apr 24, 2014 ... Sanofi-Aventis Deutschland GmbH v. ... in dispute was that the advantages provided by the claimed combination were real and not present in, ...
delivered on 17 March 2016 (1). Case C‑567/14. Genentech Inc. v. Hoechst GmbH, formerly Hoechst AG,. Sanofi-Aventis Deutschland GmbH. (Request for a ...
May 10, 2013 ... Case opinion for US Federal Circuit SANOFI AVENTIS DEUTSCHLAND GMBH v. Biogen Idec Inc., Defendant.. Read the Court's full decision ...
Apr 19, 2016 ... Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin . ... (3)Sanofi Aventis Deutschland GmbH, Berlin, Germany.
Mar 21, 2016 ... AG Opinion in Genentech v Hoechst / Sanofi case concludes that license ....  In this matter, Hoechst GmbH and Sanofi-Aventis Deutschland ...
claim construction rulings, following last year's decision in Teva v. Sandoz, which is ... Accenture Global Servs., GMBH v. ...... 129. Rambus Inc. v. Rea,. 731 F.3d 1248, 2013 WL 5312505 (Fed. Cir. Sept. .... Sanofi-Aventis Deutschland GmbH v.
Jul 28, 2014 ... Bristol-Myers Squibb Co. v. ... The name of the real party in interest (if the party named in the caption is .... Sanofi-Aventis Deutschland GmbH v.